Xponance’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-10,865
| Closed | -$1.1M | – | 1707 |
|
|
2025
Q4 | $1.1M | Buy |
10,865
+602
| +6% | +$48.3K | 0.01% | 667 |
|
|
2025
Q3 | $561K | Sell |
10,263
-224
| -2% | -$11.2K | ﹤0.01% | 924 |
|
|
2025
Q2 | $557K | Sell |
10,487
-14,485
| -58% | -$736K | ﹤0.01% | 910 |
|
|
2025
Q1 | $1.08M | Buy |
24,972
+959
| +4% | +$48.6K | 0.01% | 665 |
|
|
2024
Q4 | $1.35M | Buy |
24,013
+2,264
| +10% | +$141K | 0.01% | 622 |
|
|
2024
Q3 | $1.48M | Buy |
21,749
+173
| +0.8% | +$9.76K | 0.01% | 595 |
|
|
2024
Q2 | $912K | Buy |
21,576
+799
| +4% | +$44K | 0.01% | 700 |
|
|
2024
Q1 | $1.43M | Buy |
20,777
+8,372
| +67% | +$530K | 0.02% | 618 |
|
|
2023
Q4 | $918K | Sell |
12,405
-668
| -5% | -$43.8K | 0.01% | 701 |
|
|
2023
Q3 | $892K | Buy |
13,073
+235
| +2% | +$19.9K | 0.01% | 682 |
|
|
2023
Q2 | $1.21M | Buy |
12,838
+3,303
| +35% | +$258K | 0.02% | 604 |
|
|
2023
Q1 | $647K | Buy |
9,535
+33
| +0.3% | +$2.12K | 0.01% | 822 |
|
|
2022
Q4 | $470K | Buy |
9,502
+2,740
| +41% | +$112K | 0.01% | 916 |
|
|
2022
Q3 | $220K | Buy |
6,762
+177
| +3% | +$7.3K | ﹤0.01% | 1070 |
|
|
2022
Q2 | $259K | Sell |
6,585
-11,927
| -64% | -$638K | 0.01% | 1045 |
|
|
2022
Q1 | $1.29M | Buy |
18,512
+339
| +2% | +$24.8K | 0.02% | 508 |
|
|
2021
Q4 | $1.41M | Buy |
18,173
+6
| +0% | +$530 | 0.02% | 488 |
|
|
2021
Q3 | $1.73M | Sell |
18,167
-425
| -2% | -$44.9K | 0.03% | 377 |
|
|
2021
Q2 | $2.31M | Buy |
18,592
+5,110
| +38% | +$610K | 0.04% | 333 |
|
|
2021
Q1 | $1.78M | Buy |
13,482
+150
| +1% | +$20.5K | 0.04% | 341 |
|
|
2020
Q4 | $1.77M | Sell |
13,332
-163
| -1% | -$19.7K | 0.04% | 334 |
|
|
2020
Q3 | $1.38M | Buy |
13,495
+57
| +0.4% | +$4.92K | 0.03% | 351 |
|
|
2020
Q2 | $1.17M | Buy |
+13,438
| New | +$1.07M | 0.03% | 355 |
|
Other funds holding EXAS
PRS
PWMAG
IA
HNB
Xponance's EXAS Position: Q1 2026 in Review
Xponance sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 10,865 shares — an estimated $1.1M sold.
Xponance first reported a position in EXAS in Q2 2020 and held it in 23 quarters. The position peaked at $2.31M in Q2 2021. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Xponance reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Xponance sold 10,865 Exact Sciences shares in Q1 2026, an estimated $1.1M.
- Xponance first reported a position in Exact Sciences in Q2 2020 and held it in 23 quarters.
- Xponance's Exact Sciences position peaked at $2.31M in Q2 2021.
- 6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Xponance's 13F filing for Q1 2026, filed 13 May 2026.